Elanix and MEStar Sign LOI for China Drug Marketing JV

Elanix Biotech of Germany signed a non-binding LOI with Oxford MEStar, a spin-out from Oxford University, to form a China marketing JV. The JV will also include Tianjin-based UniNova, an affiliate of Oxford MEStar, which was founded in 2014 with $11.6 million in private investment and support of Tianjin's municipal government. UniNova was set up to facilitate access to China's market for smaller life science companies. The JV intends to bring Elanix's GynRepair to China, though specific terms remain to be worked out. More details.... Stock Symbol: (SX: ELN) Share this with colleagues: // //